关注
Nobel Bhasin
Nobel Bhasin
在 bcm.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Selective targeting of FAK–Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells
A Datta, N Bhasin, H Kim, M Ranjan, B Rider, ZY Abd Elmageed, ...
Cancer letters 362 (1), 25-35, 2015
382015
Drivers of transcriptional variance in human intestinal epithelial organoids
ZK Criss 2nd, N Bhasin, SC Di Rienzi, A Rajan, K Deans-Fielder, ...
Physiological Genomics 53 (11), 486-508, 2021
252021
Vitamin D regulation of the uridine phosphorylase 1 gene and uridine-induced DNA damage in colon in African Americans and European Americans
N Bhasin, D Alleyne, OA Gray, SS Kupfer
Gastroenterology 155 (4), 1192-1204. e9, 2018
152018
Genetic and epigenetic alterations of steroidogenic factor‑1 in ovarian tumors
S Miller, N Bhasin, H Urrego, K Moroz, BG Rowan, MS Ramayya, ...
International Journal of Oncology 42 (2), 627-634, 2013
102013
Inhibition of TRAP1 Accelerates the DNA damage response, activation of the heat shock response and metabolic reprogramming in colon cancer cells
N Bhasin, P Dabra, L Senavirathna, S Pan, R Chen
Frontiers in bioscience (Landmark edition) 28 (9), 227, 2023
32023
Deconstructing Organs: Single-Cell Analyses, Decellularized Organs, Organoids, and Organ-on-a-Chip Models: Drivers of transcriptional variance in human intestinal epithelial …
ZK Criss 2nd, N Bhasin, SC Di Rienzi, A Rajan, K Deans-Fielder, ...
Physiological Genomics 53 (11), 486, 2021
12021
DAD1 as potential therapeutic target and biomarker in prostate cancer
N Bhasin
Tulane University, 2015
12015
Significant Risk Medical Devices–Gastroenterology and Urology
M Ranjan, P Dabral, N Khurana, N Bhasin
Significant and Nonsignificant Risk Medical Devices, 179-203, 2024
2024
Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers
P Dabral, N Bhasin, M Ranjan, MM Makhlouf, ZY Abd Elmageed
Cancers 16 (13), 2462, 2024
2024
A complementary metaproteomic approach to interrogate microbiome cultivated from clinical colon biopsies
VA Duong, A Enkhbayar, N Bhasin, L Senavirathna, EC Preisner, ...
Proteomics, 2400078, 2024
2024
Cancer stem cell–derived exosomes: what is known to date
N Bhasin, P Dabral, K Selvendiran, M Anbalagan
Cancer Stem Cells and Signaling Pathways, 591-607, 2024
2024
Impact of gut microbial metabolites on colon epithelium
N Bhasin, LH Senavirathna, M Bresson, L Zhe, VB Poplaski, ZA Lami, ...
Cancer Research 83 (7_Supplement), 5299-5299, 2023
2023
Patient-Derived Xenograft Models for Studying Vascular Mimicry in Melanoma In Vivo
M Ranjan, N Bhasin
Vasculogenic Mimicry: Methods and Protocols, 85-92, 2022
2022
Metaproteomic analysis of IBD associated colorectal cancer
N Bhasin, P Dabral, V Poplaski, L Lai, HY Tsai, M Bronner, T Brentnall, ...
Cancer Research 82 (12_Supplement), 5078-5078, 2022
2022
Orthopaedics
MRN Bhasin
Toxicological Aspects of Medical Device Implants, 257-278, 2020
2020
Inter-Ethnic Differences in Colonic Response of Uridine Phosphorylase 1 (UPP1) to Vitamin D: Implications for Colorectal Cancer Disparities
N Bhasin, D Alleyne, C Cham, SS Kupfer
Gastroenterology 152 (5), S418, 2017
2017
Stem-cell based selective delivery of alpha keto reductases for therapeutic targeting of residual androgens in prostate cancer
M Ranjan, Z Abd Elmageed, H Kim, A Datta, N Bhasin, SE Braun, ...
Cancer Research 75 (15_Supplement), 3537-3537, 2015
2015
系统目前无法执行此操作,请稍后再试。
文章 1–17